Healthcare -
Biotechnology - NASDAQ - US
$ 0.371
-11.7 %
$ 1.8 M
Market Cap
-0.01
P/E
PBLA - STOCK-BASED COMPENSATION
Stock-based Compensation PBLA - Panbela Therapeutics, Inc.
823 K
LAST VALUE
-20.03%
2 YEAR CAGR
-8.44%
5 YEAR CAGR
105.93%
10 YEAR CAGR